Join
Live feed
·
INSIDERFilingvia Quantisnow
Centessa Pharmaceuticals plc logo

President, Orexin Program Accardi Mario Alberto covered exercise/tax liability with 597 units of Ordinary Shares, decreasing direct ownership by 0.29% to 207,566 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CNTA· Centessa Pharmaceuticals plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTA (Centessa Pharmaceuticals plc) and more on Quantisnow.